Abstract

Spermatogenesis is an extremely complex process, and any obstruction can cause male infertility. RhoGDIα has been identified as a risk of male sterility. In this study, we generate RhoGDIα knockout mice, and find that the males have severely low fertility. The testes from RhoGDIα−/− mice are smaller than that in WT mice. The numbers of spermatogonia and spermatocytes are decreased in RhoGDIα−/− testis. Spermatogenesis is compromised, and spermatocyte meiosis is arrested at zygotene stage in RhoGDIα−/− mice. Acrosome dysplasia is also observed in sperms of the mutant mice. At the molecular level, RhoGDIα deficiency activate the LIMK/cofilin signaling pathway, inhibiting F-actin depolymerization, impairing testis and inducing low fertility in mouse. In addition, the treatment of RhoGDIα−/− mice with Rac1 inhibitor NSC23766 alleviate testis injury and improve sperm quality by inhibiting the LIMK/cofilin/F-actin pathway during spermatogenesis. Together, these findings reveal a previously unrecognized RhoGDIα/Rac1/F-actin-dependent mechanism involved in spermatogenesis and male fertility.

RhoGDIα knockout mice show low male fertility and compromised spermatogenesis, with an underlying defect in F-actin cytoskeleton depolymerisation, which can be alleviated by inhibiting Rac1.

Details

Title
RhoGDIα regulates spermatogenesis through Rac1/cofilin/F-actin signaling
Author
Zhu, Haixia 1 ; Wen, Zongzhuang 2 ; Zhang, Aizhen 1 ; Liu, Dongyue 1 ; Wang, Hongxiang 1 ; Cheng, Yin 1 ; Yang, Xing 1 ; Xiao, Yu 1 ; Li, Jianyuan 3 ; Sun, Daqing 4   VIAFID ORCID Logo  ; Wu, Bin 5   VIAFID ORCID Logo  ; Gao, Jiangang 1   VIAFID ORCID Logo 

 Shandong University, School of Life Science and Key Laboratory of the Ministry of Education for Experimental Teratology, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174) 
 Shandong First Medical University, Medical Science and Technology Innovation Center, Jinan, China (GRID:grid.410638.8) (ISNI:0000 0000 8910 6733) 
 National Health and Family Planning Commission, Key Laboratory of Male Reproductive Health, Beijing, China (GRID:grid.453135.5) (ISNI:0000 0004 1769 3691) 
 Tianjin Medical University General Hospital, Department of Pediatric Surgery, Tianjin, China (GRID:grid.412645.0) (ISNI:0000 0004 1757 9434) 
 Central Hospital Affiliated to Shandong First Medical University, Department of Reproductive Medicine, Jinan, China (GRID:grid.410638.8) (ISNI:0000 0000 8910 6733); Shandong University, Cheeloo College of Medicine, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174) 
Pages
214
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2779291247
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.